Market Maker Surveillance Report. CHGI, TOF, AMLN, OPHC, PIP, ZLCS, Winning Stocks With Lowest Price Friction For Wednesday, M
March 28, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3828 companies with "abnormal" market making, 1969 companies with positive Friction Factors and 3893 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. CHINA CARBON GRAPHITE GROUP (OTCBB:CHGI), TOFUTTI BRANDS INC (AMEX:TOF), AMYLIN PHARMACEUTICALS INC (NASDAQ:AMLN), OPTIMUMBANK HOLDINGS INC (NASDAQ:OPHC), PHARMATHENE INC (AMEX:PIP), Zalicus Inc (NASDAQ:ZLCS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction CHGI $0.230 23.23% 70,915 38.80% 65,204 35.67% 5,711 248 TOF $0.670 44.08% 125,188 27.65% 112,143 24.77% 13,045 195 AMLN $8.510 55.30% 21,236,798 49.12% 20,726,116 47.94% 510,682 600 OPHC $1.300 76.47% 208,174 54.70% 164,323 43.18% 43,851 337 PIP $0.300 17.65% 447,111 40.58% 343,120 31.15% 103,991 3,466 ZLCS $0.200 18.52% 5,448,722 62.10% 3,325,717 37.90% 2,123,005 106,150Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows CHGI with a dollar gain Wednesday of $0.23000 and a Friction Factor of 248 shares. That means that it only took 248 more shares of buying than selling to move CHGI higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.
CHINA CARBON GRAPHITE GROUP (OTCBB:CHGI) - China Carbon Graphite Group, Inc. engages in the manufacture and sale of graphite-based products. It offers graphite electrodes that are used as electricity-conducting materials within electric arc furnaces for the manufacture of steel and non-ferrous metals, such as brown alumina, yellow phosphorus, or other metals; fine grain graphite, which is used to make graphite crucibles in various industries and continuous casting dies for non-ferrous metals and spark erosion tools in the automotive industry; and high purity graphite that is used in the chemistry, semiconductor material and precious metal smelting, food, and nuclear industries. The company sells its products through distributors to end users that consist of companies in various industries, including automobiles, defense, molding, machinery, and tool manufacturers, as well as through direct sales, which consist of the sale of the graphite electrodes to steel manufacturers and metallurgy companies; and the sale of fine grain graphite and high purity graphite products to molding companies. China Carbon Graphite Group sells its products primarily in the Peoples Republic of China, Japan, the United States, Spain, the United Kingdom, South Korea, and India. The company is based in Xinghe County, the Peoples Republic of China.
TOFUTTI BRANDS INC (AMEX:TOF) - Tofutti Brands, Inc. engages in the development, production, and marketing of nondairy frozen desserts and other food products in the United States and internationally. The company offers a product line of nondairy soy-based products, including frozen desserts, nondairy cheeses and spreads, other frozen food products, and various dry grocery items under the TOFUTTI brand. Its frozen desserts include soft serve mixes, frozen sandwiches, ice cream sandwiches, and stick novelties; nondairy cheese products comprise cream cheese, sour cream, and cheese slices; and other food products consist of pizza and frozen crepes. The company sells its products through gourmet specialty shops, kosher supermarkets, natural/health food stores, and national and regional supermarket chains. Tofutti Brands, Inc. was founded in 1981 and is based in Cranford, New Jersey.
AMYLIN PHARMACEUTICALS INC (NASDAQ:AMLN) - Amylin Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug candidates for the treatment of diabetes, obesity, and other diseases. The companys products include BYETTA (exenatide) injection for the treatment of type 2 diabetes; and SYMLIN (pramlintide acetate) injection for the treatment of type 1 and type 2 diabetes. It also has research and development (R&D) programs in the therapeutic areas of diabetes and obesity. The companys R&D programs for diabetes include exenatide once weekly, exenatide once weekly pen, exenatide suspension formulation, exenatide nasal, and the exenatide transdermal patch. Its R&D programs for obesity comprise pramlintide/metreleptin combination therapy and PYY 3-36. The company markets its products to healthcare providers, managed healthcare organizations, wholesalers and pharmacies, government purchasers, and other third-party payers primarily in the United States. It has collaboration agreements Eli Lilly and Company; Alkermes, Inc.; Takeda Pharmaceutical Company Limited; Biocon, Ltd.; and BioSeek, Inc. The company was founded in 1987 and is based in San Diego, California.
OPTIMUMBANK HOLDINGS INC (NASDAQ:OPHC) - OptimumBank Holdings, Inc. operates as the bank holding company for OptimumBank that provides community banking products and services to individuals and corporate customers in Broward, Miami-Dade, and Palm Beach counties, Florida. Its deposit products include demand interest-bearing and noninterest-bearing accounts, money market deposit accounts, NOW accounts, and time deposits, as well as direct deposits. The company also provides residential and commercial real estate loans, and consumer loans to individuals and small businesses, and other organizations. In addition, it offers credit cards, cash management, notary services, money orders, night depository, travelers checks, cashiers checks, domestic collections, savings bonds, bank drafts, automated teller services, drive-in tellers, and banking by mail services. Further, the company provides Internet banking services. It conducts operations from its Fort Lauderdale headquarters and three branch offices in Fort Lauderdale, Plantation, and Deerfield Beach. The company was founded in 2000 and is headquartered in Fort Lauderdale, Florida.
PHARMATHENE INC (AMEX:PIP) - PharmAthene, Inc., a biodefense company, together with its subsidiaries, engages in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States. Its product candidates include SparVax, a recombinant protective antigen (rPA) anthrax vaccine to protect against inhalation anthrax that has completed one Phase I and two Phase II clinical trials; and Valortim, a human monoclonal antibody to protect against and treat human inhalational anthrax, which has completed Phase I clinical trial. The companys product candidates also include Protexia, a recombinant enzyme (butyrylcholinesterase), which mimics a natural bioscavenger for the prevention or treatment of nerve agent poisoning by organophosphate compounds, including nerve gases and pesticides. In addition, its product candidates include RypVax, a recombinant plague vaccine comprising separate recombinant F1 (rF1) and V (rV) antigens produced in Escherichia coli, which completed three Phase I human clinical trials; and rPA anthrax vaccine, which does not require refrigeration. The companys customers include National Institute of Allergy and Infectious Diseases, the U.S. Department of Defense, Biomedical Advanced Research and Development Authority, and the U.S. National Institutes of Health. It has a collaboration agreement with Medarex, Inc. to develop and commercialize Valortim. PharmAthene, Inc. was founded in 2001 and is based in Annapolis, Maryland.
Zalicus Inc (NASDAQ:ZLCS) -
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net